Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
Status:
Recruiting
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
The investigator's goal in this study is to determine the clinical efficacy and safety of
continuous infusion in comparison with standard intermittent infusion.
Phase:
N/A
Details
Lead Sponsor:
October 6 University
Collaborators:
Beni-Suef University Critical Care Department,Cairo University Hospitals